Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Genomics & Proteomics
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Cancer Genomics & Proteomics

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

Table of Contents

May-June 2023; Volume 20,Issue 3

Reviews

  • Open Access
    Biospecimen Digital Twins: Moving from a “High Quality” to a “Fit-for-Purpose” Concept in the Era of Omics Sciences
    UMBERTO NANNI, PATRIZIA FERRONI, SILVIA RIONDINO, ANTONELLA SPILA, MARIA GIOVANNA VALENTE, GIROLAMO DEL MONTE, MARIO ROSELLI and FIORELLA GUADAGNI
    Cancer Genomics & Proteomics May 2023, 20 (3) 211-221; DOI: https://doi.org/10.21873/cgp.20376
  • Open Access
    Breast Cancer: Circular RNAs Mediating Efficacy in Preclinical In Vivo Models
    ULRICH H. WEIDLE, HUNG-EN HSIA and ULRICH BRINKMANN
    Cancer Genomics & Proteomics May 2023, 20 (3) 222-238; DOI: https://doi.org/10.21873/cgp.20377

Articles

  • Open Access
    A Bioinformatics Assessment Indicating Better Outcomes With Breast Cancer Resident, Immunoglobulin CDR3-MMP2 Binding
    SUHAAS R. MANDALA, ALEXIS J. THOMSON, ETIENNE C. GOZLAN, DHRUV N. PATEL, ANDREA CHOBRUTSKIY, BORIS I. CHOBRUTSKIY and GEORGE BLANCK
    Cancer Genomics & Proteomics May 2023, 20 (3) 239-246; DOI: https://doi.org/10.21873/cgp.20378
  • Open Access
    The Role of Apoptotic Genes and Protein-Protein Interactions in Triple-negative Breast Cancer
    GETINET M. ADINEW, SAMIA MESSEHA, EQUAR TAKA, SHADE A. AHMED and KARAM F.A. SOLIMAN
    Cancer Genomics & Proteomics May 2023, 20 (3) 247-272; DOI: https://doi.org/10.21873/cgp.20379
  • Open Access
    A Multiplex Biomarker Assay Improves the Prediction of Survival in Epithelial Ovarian Cancer
    ARTURAS DOBILAS, ANNA ÅKESSON, PIA LEANDERSSON and CHRISTER BORGFELDT
    Cancer Genomics & Proteomics May 2023, 20 (3) 273-280; DOI: https://doi.org/10.21873/cgp.20380
  • Open Access
    Knockdown of G Protein-coupled Estrogen Receptor 1 (GPER1) Enhances Tumor-supportive Properties in Cervical Carcinoma Cells
    SOPHIA RUCKRIEGL, JOHANNA LORIS, KATSIARYNA WERT, GERD BAUERSCHMITZ, JULIA GALLWAS and CARSTEN GRÜNDKER
    Cancer Genomics & Proteomics May 2023, 20 (3) 281-297; DOI: https://doi.org/10.21873/cgp.20381
  • Open Access
    Loss of F-Box and Leucine Rich Repeat Protein 5 (FBXL5) Expression Is Associated With Poor Survival in Patients With Hepatocellular Carcinoma After Curative Resection: A Two-institute Study
    YOON AH CHO, SUNG-EUN KIM, CHEOL KEUN PARK, HYUN HEE KOH, CHEOL-KEUN PARK and SANG YUN HA
    Cancer Genomics & Proteomics May 2023, 20 (3) 298-307; DOI: https://doi.org/10.21873/cgp.20382
  • Open Access
    Combination of Urinary MiR-501 and MiR-335 With Current Clinical Diagnostic Parameters as Potential Predictive Factors of Prostate Biopsy Outcome
    JAROSLAV JURACEK, MARIE MADRZYK, KAROLINA TRACHTOVA, MICHAELA RUCKOVA, JULIA BOHOSOVA, DOMINIK A. BARTH, MARTIN PICHLER, MICHAL STANIK and ONDREJ SLABY
    Cancer Genomics & Proteomics May 2023, 20 (3) 308-316; DOI: https://doi.org/10.21873/cgp.20383
Back to top
Previous

In this issue

Cancer Genomics - Proteomics: 20 (3)
Cancer Genomics & Proteomics
Vol. 20, Issue 3
May-June 2023
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)

Issue highlights

  • The Role of Apoptotic Genes and Protein-Protein Interactions in Triple-negative Breast Cancer
  • A Bioinformatics Assessment Indicating Better Outcomes With Breast Cancer Resident, Immunoglobulin CDR3-MMP2 Binding
  • A Multiplex Biomarker Assay Improves the Prediction of Survival in Epithelial Ovarian Cancer
  • Knockdown of G Protein-coupled Estrogen Receptor 1 (GPER1) Enhances Tumor-supportive Properties in Cervical Carcinoma Cells
  • Combination of Urinary MiR-501 and MiR-335 With Current Clinical Diagnostic Parameters as Potential Predictive Factors of Prostate Biopsy Outcome
Sign up for alerts

Jump to

  • Reviews
  • Articles
  • Top Topics
  • Most Cited
  • Most Read
Loading
Breast Cancer Metastasis
Applications of Support Vector Machine (SVM) Learning in Cancer Genomics
Cancer-related Issues of CD147
Long Non-coding RNAs and their Role in Metastasis
The Multiple Roles of Exosomes in Metastasis
Screening for Epigenetically Masked Genes in Colorectal Cancer Using 5-Aza-2’-deoxycytidine, Microarray and Gene Expression Profile
Cancer & Genome Proteomics

© 2023 Cancer Genomics & Proteomics

Powered by HighWire